AMANDA ROBERTS: Open Payments
NPI 1891466843 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 82 payments from 19 companies in 2025. Trend: 2023 $1,149 · 2024 $1,443 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $367 |
| Supernus Pharmaceuticals, Inc. | 11 | $241 |
| Otsuka America Pharmaceutical, Inc. | 10 | $165 |
| Axsome Therapeutics, Inc. | 5 | $129 |
| Alkermes, Inc. | 6 | $98 |
| Neos Therapeutics, LP | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Corium, LLC | 2 | $40 |
Products named: VRAYLAR, Qelbree, Auvelity, REXULTI, VIVITROL, Adzenys XR-ODT, ABILIFY ASIMTUFII, HETLIOZ.
Industry payments across IN — which companies pay providers there.
